share_log

Earnings Preview: MCRB to Report Financial Results Pre-market on November 13

Moomoo News ·  Nov 8, 2024 04:45

$Seres Therapeutics (MCRB.US)$ is scheduled to release its financial results pre-market on November 13 ET.

Earnings Preview

Analysts estimate $Seres Therapeutics (MCRB.US)$ to post revenue of USD25.83M for 2024Q3, up 8233.33% YOY;

EPS is estimated to be USD-0.08, Net Loss Narrowed 78.94% YoY.

The accounting standard used for the above data is US-GAAP.

mm_stock_outlook_71343701964975_2024Q3_1731508200_1_1731012301011_en

Note:

  1. US-listed companies have full discretion in choosing their accounting year-end date, without being subject to any mandatory requirements. Consequently, every financial reporting period can act as the annual report cutoff date for a company, rather than following a natural calendar year as the fiscal year.

  2. Typically, companies host conference call around the date of the financial report publication to discuss the most recent financial results and operational performance while engaging with investors, analysts, and media. Investors are free to attend either through offline meetings or online conference calls.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment